I completed my Honours degree in Nanotechnology (Biochemistry stream) at Flinders University while also working as a laboratory technician in the Department of Ophthalmology. My Honours and PhD research on the histamine and serotonin receptors was carried out in the laboratory of Prof. Edward J McMurchie at CSIRO in Adelaide and Parkville, in conjunction with Dr Ian Menz (Flinders). I also worked as research assistant in Prof. McMurchie’s laboratory before beginning my PhD.
Following my PhD, I worked with Dr Reinhard Grisshammer at the National Institutes of Health (NIH) on the neurotensin-1 receptor, before changing my research focus to virology: a field I was especially interested in. With Dr Alan Rein at the National Cancer Institute (NIH), I developed assays for the detection of replication-competent retroviruses in gene-therapy products and contributed to the rapid investigations into a novel proposed human pathogen, Xenotropic Murine Leukemia Virus (XMRV).
I returned to Adelaide in 2012 to work on Hepatitis C Virus (HCV) with Assoc. Prof. Michael Beard, where I developed a novel HCV cell culture model and assessed the efficacy of direct-acting antivirals in collaboration with researchers from Merck Sharpe and Dohme. Returning to Flinders University in 2015, I worked with Dr Jill Carr on the inflammatory responses associated with Dengue Virus (DENV) infection.
I now manage the research facility, Cell Screen SA, within the Flinders Centre for Innovation in Cancer.
B.Sc. in Nanotechnology, Biochemistry (Honours), Flinders University, 2003
PhD in Biochemistry, Flinders University, 2008
Manager of Cell Screen SA (CeSSA), a research facility in the Flinders Centre for Innovation in Cancer. CeSSA has advanced, automated imaging and image analysis, plate reading and liquid handling equipment. We are equipped to conduct RNAi and small molecule library screening. CeSSA is the only facility of its type in South Australia. The facility works with researchers from a large variety of scientific fields and helps them to advance their work using the latest technologies.
You consent to the use of our cookies if you proceed.